Korea expands telemedicine drug delivery; 60‑day eye‑drop case

The Korean government is moving forward with the institutionalisation of telemedicine and is now actively discussing the expansion of drug delivery services to all patients. A recent report highlighted a case in which a single‑use 0.3% hyaluronic‑acid sodium eye drop was prescribed via telemedicine for a 60‑day period: one tube per dose, administered six times daily, amounting to a full two‑month supply. Industry observers warn that as telemedicine’s accessibility and convenience grow, safeguards for long‑term, high‑volume prescriptions and mechanisms to manage health‑insurance finances must be carefully examined.